Here's What Key Metrics Tell Us About Intuitive Surgical (ISRG) Q3 Earnings

For the quarter ended September 2025, Intuitive Surgical, Inc. (ISRG) reported revenue of $2.51 billion, up 22.9% over the same period last year. EPS came in at $2.40, compared to $1.84 in the year-ago quarter.The reported revenue represents a surprise of +3.92% over the Zacks Consensus Estimate of $2.41 billion. With the consensus EPS estimate being $1.99, the EPS surprise was +20.6%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Intuitive Surgical performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Total System Units Placed - Total Company: 427 compared to the 434 average estimate based on four analysts.Da Vinci Surgical System Installed Base: 10,763 compared to the 10,838 average estimate based on three analysts.Instruments and accessories Revenue- United States: $1.06 billion versus the two-analyst average estimate of $1.03 billion. The reported number represents a year-over-year change of +17.4%.Systems Revenue- United States: $397.5 million compared to the $307.48 million average estimate based on two analysts. The reported number represents a change of +49.8% year over year.Instruments and accessories Revenue- Outside of the United States: $456.8 million compared to the $438.66 million average estimate based on two analysts. The reported number represents a change of +27.1% year over year.Geographic Revenue- United States: $1.72 billion compared to the $1.58 billion average estimate based on two analysts. The reported number represents a change of +24.5% year over year.Service Revenue- United States: $258.1 million versus $247.97 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +23.4% change.Service Revenue- Outside of the United States: $137.8 million compared to the $138.34 million average estimate based on two analysts. The reported number represents a change of +15.1% year over year.Revenue- Product (Instruments and accessories and Systems): $2.11 billion versus $2.02 billion estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +23.4% change.Revenue- Services: $395.9 million versus the seven-analyst average estimate of $387.11 million. The reported number represents a year-over-year change of +20.4%.Revenue- Systems: $590.4 million versus the seven-analyst average estimate of $543.22 million. The reported number represents a year-over-year change of +32.7%.Revenue- Instruments and accessories: $1.52 billion versus $1.47 billion estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +20.1% change.View all Key Company Metrics for Intuitive Surgical here>>>Shares of Intuitive Surgical have returned +3.4% over the past month versus the Zacks S&P 500 composite's +1.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.See "2nd Wave" AI stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intuitive Surgical, Inc. (ISRG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks